Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation.

The urinary metabolites (Z)-7-[1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid (8-iso-PGF2α), an F2-isoprostane and biomarker of oxidative damage, and "prostaglandin E2 metabolite" (PGE-M), a biomarker of inflammation, are elevated in cigarette smoker...

Full description

Bibliographic Details
Main Authors: Steven G Carmella, Alisa K Heskin, Mei Kuen Tang, Joni Jensen, Xianghua Luo, Chap T Le, Sharon E Murphy, Neal L Benowitz, F Joseph McClernon, Ryan Vandrey, Sharon S Allen, Rachel Denlinger-Apte, Paul M Cinciripini, Andrew A Strasser, Mustafa al'Absi, Jason D Robinson, Eric C Donny, Dorothy K Hatsukami, Stephen S Hecht
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0215853
id doaj-824384ab320143819c8dbbe5c51ad161
record_format Article
spelling doaj-824384ab320143819c8dbbe5c51ad1612021-03-03T21:33:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01144e021585310.1371/journal.pone.0215853Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation.Steven G CarmellaAlisa K HeskinMei Kuen TangJoni JensenXianghua LuoChap T LeSharon E MurphyNeal L BenowitzF Joseph McClernonRyan VandreySharon S AllenRachel Denlinger-AptePaul M CinciripiniAndrew A StrasserMustafa al'AbsiJason D RobinsonEric C DonnyDorothy K HatsukamiStephen S HechtThe urinary metabolites (Z)-7-[1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid (8-iso-PGF2α), an F2-isoprostane and biomarker of oxidative damage, and "prostaglandin E2 metabolite" (PGE-M), a biomarker of inflammation, are elevated in cigarette smokers. However, there is little information in the literature on the longitudinal stability of these widely used biomarkers. In a large clinical trial involving 10 institutional sites, smokers were given, free of charge over a period of 20 weeks, Spectrum NRC600/601 research cigarettes containing 15.5 mg nicotine/g tobacco. All participants were instructed to smoke these cigarettes for the duration of the study. At weeks 4, 8, 12, 16, and 20, first morning urine voids were collected and analyzed for 8-iso-PGF2α and PGE-M using validated liquid chromatography-electrospray ionization-tandem mass spectrometry methods. The mean level of 8-iso-PGF2α at Week 4 was 1.34 ± 1.08 (S.D.) pmol/mg creatinine (N = 226) while that of PGE-M was 73.7 ± 113 (S.D.) pmol/mg creatinine (N = 232). The corresponding levels at Week 20 were 1.35 ± 0.93 (S.D.) pmol/mg creatinine (N = 209) for 8-iso-PGF2α and 74.2 ± 142 (S.D.) pmol/mg creatinine (N = 210) for PGE-M. There was variation in these values in the intervening weeks. The intra-class correlation coefficients (ICC) were 0.51 (95% CI, 0.45, 0.57) and 0.36 (0.30, 0.43), for 8-iso-PGF2α and PGE-M, respectively, indicating fair longitudinal stability for 8-iso-PGF2α and poorer longitudinal stability for PGE-M in cigarette smokers. Males had higher ICC values than females for both 8-iso-PGF2α and PGE-M. These results indicate that, in addition to cigarette smoking, endogenous processes of oxidative damage and inflammation influence the levels of these biomarkers over time among current smokers.https://doi.org/10.1371/journal.pone.0215853
collection DOAJ
language English
format Article
sources DOAJ
author Steven G Carmella
Alisa K Heskin
Mei Kuen Tang
Joni Jensen
Xianghua Luo
Chap T Le
Sharon E Murphy
Neal L Benowitz
F Joseph McClernon
Ryan Vandrey
Sharon S Allen
Rachel Denlinger-Apte
Paul M Cinciripini
Andrew A Strasser
Mustafa al'Absi
Jason D Robinson
Eric C Donny
Dorothy K Hatsukami
Stephen S Hecht
spellingShingle Steven G Carmella
Alisa K Heskin
Mei Kuen Tang
Joni Jensen
Xianghua Luo
Chap T Le
Sharon E Murphy
Neal L Benowitz
F Joseph McClernon
Ryan Vandrey
Sharon S Allen
Rachel Denlinger-Apte
Paul M Cinciripini
Andrew A Strasser
Mustafa al'Absi
Jason D Robinson
Eric C Donny
Dorothy K Hatsukami
Stephen S Hecht
Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation.
PLoS ONE
author_facet Steven G Carmella
Alisa K Heskin
Mei Kuen Tang
Joni Jensen
Xianghua Luo
Chap T Le
Sharon E Murphy
Neal L Benowitz
F Joseph McClernon
Ryan Vandrey
Sharon S Allen
Rachel Denlinger-Apte
Paul M Cinciripini
Andrew A Strasser
Mustafa al'Absi
Jason D Robinson
Eric C Donny
Dorothy K Hatsukami
Stephen S Hecht
author_sort Steven G Carmella
title Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation.
title_short Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation.
title_full Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation.
title_fullStr Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation.
title_full_unstemmed Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation.
title_sort longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2019-01-01
description The urinary metabolites (Z)-7-[1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid (8-iso-PGF2α), an F2-isoprostane and biomarker of oxidative damage, and "prostaglandin E2 metabolite" (PGE-M), a biomarker of inflammation, are elevated in cigarette smokers. However, there is little information in the literature on the longitudinal stability of these widely used biomarkers. In a large clinical trial involving 10 institutional sites, smokers were given, free of charge over a period of 20 weeks, Spectrum NRC600/601 research cigarettes containing 15.5 mg nicotine/g tobacco. All participants were instructed to smoke these cigarettes for the duration of the study. At weeks 4, 8, 12, 16, and 20, first morning urine voids were collected and analyzed for 8-iso-PGF2α and PGE-M using validated liquid chromatography-electrospray ionization-tandem mass spectrometry methods. The mean level of 8-iso-PGF2α at Week 4 was 1.34 ± 1.08 (S.D.) pmol/mg creatinine (N = 226) while that of PGE-M was 73.7 ± 113 (S.D.) pmol/mg creatinine (N = 232). The corresponding levels at Week 20 were 1.35 ± 0.93 (S.D.) pmol/mg creatinine (N = 209) for 8-iso-PGF2α and 74.2 ± 142 (S.D.) pmol/mg creatinine (N = 210) for PGE-M. There was variation in these values in the intervening weeks. The intra-class correlation coefficients (ICC) were 0.51 (95% CI, 0.45, 0.57) and 0.36 (0.30, 0.43), for 8-iso-PGF2α and PGE-M, respectively, indicating fair longitudinal stability for 8-iso-PGF2α and poorer longitudinal stability for PGE-M in cigarette smokers. Males had higher ICC values than females for both 8-iso-PGF2α and PGE-M. These results indicate that, in addition to cigarette smoking, endogenous processes of oxidative damage and inflammation influence the levels of these biomarkers over time among current smokers.
url https://doi.org/10.1371/journal.pone.0215853
work_keys_str_mv AT stevengcarmella longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
AT alisakheskin longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
AT meikuentang longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
AT jonijensen longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
AT xianghualuo longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
AT chaptle longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
AT sharonemurphy longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
AT neallbenowitz longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
AT fjosephmcclernon longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
AT ryanvandrey longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
AT sharonsallen longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
AT racheldenlingerapte longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
AT paulmcinciripini longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
AT andrewastrasser longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
AT mustafaalabsi longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
AT jasondrobinson longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
AT ericcdonny longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
AT dorothykhatsukami longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
AT stephenshecht longitudinalstabilityincigarettesmokersofurinaryeicosanoidbiomarkersofoxidativedamageandinflammation
_version_ 1714816272318857216